7.65 (0.47%) Sun Pharmaceutical Industries has informed about submission of press release relating to launch of Ezallor Sprinkle (Rosuvastatin) in US, which the Company shall be releasing after sending this letter.
The above information is a part of company’s filings submitted to BSE.